Conference
Benefit from exemestane (EXE) as extended adjuvant therapy after 5 years of tamoxifen (TAM): intent-to-treat analysis of NSABP B-33.
Authors
Mamounas E; Jeong J-H; Wickerham L; Smith R; Geyer C; Ganz P; Land S; Hutchins L; Eisen A; Ingle J
Volume
100
Pagination
pp. S22-S22
Publisher
SPRINGER
Publication Date
January 1, 2006
Name of conference
29th Annual San Antonio Breast Cancer Symposium
Conference place
TX, San Antonio
Conference start date
December 14, 2006
Conference end date
December 17, 2006
Conference proceedings
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806